The research group of Prof. Wanliang Lu revealed a novel oncogenic enhancer of estrogen receptor-positive breast cancer

Journal of Chinese Pharmaceutical Sciences ›› 2022, Vol. 31 ›› Issue (9): 723-724.

• News • Previous Articles Next Articles

The research group of Prof. Wanliang Lu revealed a novel oncogenic enhancer of estrogen receptor-positive breast cancer

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2022-09-15 Revised:2022-09-16 Accepted:2022-09-17 Online:2022-09-30 Published:2022-10-03

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research group of Prof. Wanliang Lu revealed a novel oncogenic enhancer of estrogen receptor-positive breast cancer[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(9): 723-724.

The research group of Prof. Wanliang Lu revealed a novel oncogenic enhancer of estrogen receptor-positive breast cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments